MEDPRIN REGENERATIVE MEDICAL TECHNOLOGIES CO., LTD.

Medprin Regenerative Medical Technologies Co., Ltd.

Equities

301033

CNE100004NB8

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-06-26 pm EDT			5-day change	1st Jan Change
38.78 ^CNY	-1.40%		+0.21%	-10.93%

May. 13	Medprin Regenerative Medical Technologies Co., Ltd. Approves Board Appointments	CI
May. 13	Medprin Regenerative Medical Technologies Co., Ltd. Approves Cash Dividend for the Year 2023	CI

Tranche Update on Medprin Regenerative Medical Technologies Co., Ltd.'s Equity Buyback Plan announced on February 23, 2024.

May 10, 2024 at 08:42 am EDT

From April 1, 2024 to May 10, 2024, the company has repurchased 79,600 shares, representing 0.12% for CNY 2.51 million. With this, the company has completed the repurchase of 352,500 shares, representing 0.54% for CNY 11.5 million under the buyback announced on February 23, 2024.

Latest news about Medprin Regenerative Medical Technologies Co., Ltd.

Medprin Regenerative Medical Technologies Co., Ltd. Approves Board Appointments	May. 13	CI
Medprin Regenerative Medical Technologies Co., Ltd. Approves Cash Dividend for the Year 2023	May. 13	CI
Tranche Update on Medprin Regenerative Medical Technologies Co., Ltd.'s Equity Buyback Plan announced on February 23, 2024.	May. 10	CI
Medprin Regenerative Medical Technologies Co., Ltd.'s Equity Buyback announced on February 23, 2024, has closed with 352,500 shares, representing 0.54% for CNY 11.5 million.	May. 09	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 18	CI
Tranche Update on Medprin Regenerative Medical Technologies Co., Ltd.'s Equity Buyback Plan announced on February 23, 2024.	Apr. 01	CI
Medprin Regenerative Medical Technologies Co., Ltd. announces an Equity Buyback for CNY 20 million worth of its shares.	Feb. 22	CI
Medprin Regenerative Medical Technologies Co., Ltd. authorizes a Buyback Plan.	Feb. 21	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-18	CI
Certain A Shares of Medprin Regenerative Medical Technologies Co., Ltd. are subject to a Lock-Up Agreement Ending on 26-JUL-2023.	23-07-25	CI
Medprin Regenerative Medical Technologies Co., Ltd. Approves Final Cash Dividend for the Year 2022, Payable on 01 June 2023	23-05-19	CI
Medprin Regenerative Medical Technologies Co., Ltd. Proposes Profit Distribution of Cash Dividend for the Year 2022	23-04-27	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Medprin Regenerative Medical Gets Marketing Nod in China for Craniofacial Fixation Plate	23-03-14	MT
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-12	CI
Certain A Shares of Medprin Regenerative Medical Technologies Co., Ltd. are subject to a Lock-Up Agreement Ending on 26-JUL-2022.	22-07-25	CI
Medprin Regenerative Medical Technologies to Free Up 2.5% Stake For Trading	22-07-21	MT
Medprin Regenerative Medical Technologies Co., Ltd. Approves Profit Distribution Plan for 2021	22-05-13	CI
Medprin Regenerative Medical Technologies Co., Ltd. Announces Profit Distribution for 2021	22-04-21	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-20	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-26	CI
Medprin Regenerative Medical Technologies Co., Ltd. has completed an IPO in the amount of CNY 250.048697 million.	21-07-15	CI

Chart Medprin Regenerative Medical Technologies Co., Ltd.

Duration

Period

Chart Medprin Regenerative Medical Technologies Co., Ltd.

More charts

Company Profile

Medprin Regenerative Medical Technologies Co Ltd is a China-based company principally engaged in the research and development, production and sales of high-performance implantable medical devices. The Company's implanted medical device products include artificial dura mater (spine) patch, cranio-maxillofacial repair products and absorbable hemostatic yarns. 3D printing equipment includes biological 3D printers, resin 3D printers and other related supporting components. Technical services include general technical services and scientific research services. The Company distributes its products both in the domestic market and to overseas markets.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-11 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
MEDPRIN REGENERATIVE MEDICAL TECHNOLOGIES CO., LTD.	-10.93%	358M
STRYKER CORPORATION	+13.77%	130B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-17.54%	7.37B
GLAUKOS CORPORATION	+46.71%	5.87B
INSPIRE MEDICAL SYSTEMS, INC.	-32.92%	4.1B
AXONICS, INC.	+8.20%	3.44B
ENOVIS CORPORATION	-19.89%	2.47B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-16.33%	1.94B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-24.61%	1.72B
DOUBLE MEDICAL TECHNOLOGY INC.	-36.56%	1.51B

Medical Devices & Implants